Résumés
Résumé
Bien que le traitement hormonal substitutif (hormone replacement therapy, HRT) soit le traitement le plus efficace des symptômes associés à la ménopause, des études plus récentes et plus rigoureuses confirment que les risques associés au HRT peuvent dépasser les bénéfices escomptés. Dans ce contexte, de plus en plus de femmes se tournent vers des solutions dites «naturelles», comme les phytooestrogènes, afin de soulager les malaises associés à la ménopause. Cet article passe en revue les effets des phytooestrogènes sur la réduction de ces symptômes et sur les risques de maladies cardiovasculaires, d’ostéoporose et de cancer du sein.
Summary
Many women seek alternatives to hormone replacement therapy (HRT). Phytoestrogens are nonsteroidal compounds with estrogenic or antiestrogenic properties. Six of the 16 clinical trials suggest a significant reduction in alleviating symptoms but to a lesser degree than HRT. A meta-analysis showed that phytoestrogens improve lipid profile. The 14 recent clinical trials led, however, to divergent findings. Small clinical trials suggested a protective effect of phytoestrogens on bone metabolism. High concentration of phytoestrogens was associated with a reduction in breast cancer risk in case-control studies.
Parties annexes
Références
- 1. OMS.Stratégie de l’OMS pour la médecine traditionnelle pour 2002-2005. Genève : Organisation mondiale de la Santé, 2002 : 1-78.
- 2. Harris P, Rees R. The prevalence of complementary and alternative medicine use among the general population : a systematic review of the literature. Compl Ther Med 2000 ; 8 : 88-96.
- 3. Eisenberg DM, Kessler RC, Van Rompay MI, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both : results from a national survey. Ann Intern Med 2001 ; 135 : 344-51.
- 4. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002 ; 288 : 321-33.
- 5. Ross JA, Kasum CM. Dietary flavonoids : bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002 ; 22 : 19-34.
- 6. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome : the Japanese case. Maturitas 1988 ; 10 : 317-32.
- 7. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms : a review of randomized, controlled trials. Ann Intern Med 2002 ; 137 : 805-13.
- 8. Setchell KD, Brown NM, Zimmer-Nechemias L, et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002 ; 76 : 447-53.
- 9. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002 ; 3 : 364-73.
- 10. Anthony MS. Soy and cardiovascular disease : cholesterol lowering and beyond. J Nutr 2000 ; 130 : 662S-3S.
- 11. Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression : a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001 ; 86 : 41-7.
- 12. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995 ; 333 : 276-82.
- 13. Warren MP, Shortle B, Dominguez JE. Use of alternative therapies in menopause. Best Pract Res Clin Obstet Gynaecol 2002 ; 16 : 411-48.
- 14. Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002 ; 87 : 1527-32.
- 15. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 2002 ; 100 : 495-504.
- 16. Uesugi T, Fukui Y, Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women : a four-week study. J Am Coll Nutr 2002 ; 21 : 97-102.
- 17. Wangen KE, Duncan AM, Merz-Demlow BE, et al. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000 ; 85 : 3043-8.
- 18. Horn-Ross PL, John EM, Lee M, et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population : the Bay Area Breast Cancer Study. Am J Epidemiol 2001 ; 154 : 434-41.
- 19. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002 ; 23 : 1491-6.
- 20. Shu XO, Jin F, Dai Q, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001 ; 10 : 483-8.
- 21. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998 ; 68 : 1431S-1435S.
- 22. Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999 ; 84 : 4017-24.
- 23. Maskarinec G, Williams AE, Carlin L. Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 2003 ; 12 : 165-9.
- 24. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999 ; 2 : 85-92.
- 25. Dalais FS, Rice GE, Wahlqvist ML, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998 ; 1 : 124-9.
- 26. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000 ; 7 : 236-42.
- 27. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001 ; 8 : 17-26.
- 28. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999 ; 2 : 79-84.
- 29. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors. A North Central cancer treatment group trial. J Clin Oncol 2000 ; 18 : 1068-74.
- 30. Han KK, Soares JM, Jr., Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002 ; 99 : 389-94.
- 31. Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flushes effect of soy and wheat. Maturitas 1995 ; 21 : 189-95.
- 32. Knight DC, Howes JB, Eden JA, Howes LG. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric 2001 ; 4 : 13-8.
- 33. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women a pilot study. Menopause 2000 ; 7 : 105-11.
- 34. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer a randomized, controlled clinical trial. J Clin Oncol 2002 ; 20 : 1449-55.
- 35. Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000 ; 3 : 161-7.
- 36. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999 ; 6 : 7-13.
- 37. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998 ; 91 : 6-11.
- 38. Brzezinski A, Adlercreutz H, Shaoul R, Rosler A, Shmueli A, Tanos Vea. Short-term effect of phytoestrogen-rich diet on postmenopausal women. Menopause 1997 ;4 : 89-94.
- 39. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995 ; 80 : 1685-90.
- 40. Chiechi LM, Secreto G, D’Amore M, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis the Menfis randomized trial. Maturitas 2002 ; 42 : 295-300.
- 41. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001 ; 8 : 259-65.
- 42. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000 ; 72 : 844-52.
- 43. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998 ; 68: 1375S-9S.
- 44. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002 ; 11 : 815-21.
- 45. Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H. Serum enterolactone and risk of breast cancer a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 2001 ; 10 : 339-44.
- 46. McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 2002 ; 132 : 3036-41.
- 47. Zheng W, Dai Q, Custer LJ, et al. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999 ; 8 : 35-40.
- 48. den Tonkelaar I, Keinan-Boker L, Veer PV, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001 ; 10 : 223-8.
- 49. Murkies A, Dalais FS, Briganti EM, et al. Phytoestrogens and breast cancer in postmenopausal women a case control study. Menopause 2000 ; 7 : 289-96.
- 50. Torres-Sanchez L, Lopez-Carrillo L, Lopez-Cervantes M, Rueda-Neria C, Wolff MS. Food sources of phytoestrogens and breast cancer risk in Mexican women. Nutr Cancer 2000 ; 37 : 134-9.
- 51. Dai Q, Shu XO, Jin F, et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 2001 ; 85 : 372-8.
- 52. Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996 ; 5 : 901-6.
- 53. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997 ; 350 : 990-4.
- 54. Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW. Diet and premenopausal bilateral breast cancer a case-control study. Breast Cancer Res Treat 1997 ; 42 : 243-51.